Jostens Announces $640 Million Dividend Recap
Koch Equity Development invests $450 million, will own minority stake in the business LOS ANGELES (November 12, 2024)...
Company overview
- Headquartered in Mumbai, Inventia is a supplier in both semi-finished and finished Oral Solid Dosage (OSD) formulations for both regular and value-added generics.
- Inventia partners with global and leading local pharmaceuticals companies that sell in more than 40 countries across North America, South America, Europe, Southeast Asia, Middle East and Africa.
- Inventia operates both a manufacturing facility in Ambernath and a research and development facility in Thane in Maharashtra, India. The company's manufacturing platform is accredited by the U.S. FDA, U.K. MHRA and other Stringent Regulatory Authorities ("SRA").
Post 
In 
Email 
Copy link